Investors

Investors hub

We provide academic and commercial organisations worldwide with market-leading scientific technology and expertise.

Innovation is the driving force behind our growth and success, supporting our core purpose to accelerate the breakthroughs that create a brighter future for our world.

We hold a unique position to anticipate global drivers and connect academic and commercial researchers, acting as a catalyst that powers real world progress.

FY26 adjusted financial highlights*

Revenue
£m
(3.0%) organic constant currency (OCC)*
Operating profit (OCC)
£m
(1.6%)
Operating profit margin
%
(50) basis points
Operating profit margin (OCC)
%
+30 basis points
Net cash
£m
Dividend
p
Basic earnings per share
p

*Adjusted items exclude the amortisation and impairment of acquired intangible assets, acquisition items, business reorganisation costs, other significant non-recurring items, and the mark-to-market movement of financial derivatives. References to year-on-year movements and margin percentages are shown at organic constant currency (OCC), prepared using prior year results translated at the current reporting year’s average exchange rates excluding disposals, and acquisitions are not included until the prior year includes a full year of performance. Comparators have been restated to reclassify NanoScience business as a discontinued operation. For full details see Financial Review and Financial Statements.